Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PYC Therapeutics Limited (AU:PYC)
ASX:PYC
RESEARCH TOOLSreports
Holding AU:PYC?
Track your performance easily
PYC Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.72 - AU$2.10
Previous CloseAU$1.82
Volume0.00
Average Volume (3M)474.84K
Market Cap
AU$813.90M
Enterprise ValueAU$786.58M
Total Cash (Recent Filing)AU$29.11M
Total Debt (Recent Filing)AU$943.77K
Price to Earnings (P/E)―
Beta-0.14
Next Earnings
Feb 27, 2025EPS Estimate
-AU$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares OutstandingN/A
10 Day Avg. Volume203,535
30 Day Avg. Volume474,837
Standard Deviation0.16
R-Squared0.01
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)26.88
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.32Price Target Upside-82.41% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
PYC Therapeutics Limited News
PremiumCompany Announcements
PYC Therapeutics Advances VP-001 for Eye Disease
PremiumCompany Announcements
PYC Therapeutics Announces Security Consolidation
PremiumCompany Announcements
PYC Therapeutics Secures Shareholder Approval at AGMPremiumCompany Announcements
PYC Therapeutics to Unveil Pioneering RNA Therapy DataPremiumCompany Announcements
PYC Therapeutics Announces Security Consolidation Plan
PremiumCompany Announcements
PYC Therapeutics Advances in Eye Disease Treatment Trials
PremiumCompany Announcements
PYC Therapeutics Advances Clinical Trial for ADOA Treatment
PremiumCompany Announcements
PYC Therapeutics Advances in Eye Disease TreatmentPYC FAQ
What was PYC Therapeutics Limited’s price range in the past 12 months?
PYC Therapeutics Limited lowest share price was AU$0.72 and its highest was AU$2.10 in the past 12 months.
What is PYC Therapeutics Limited’s market cap?
Currently, no data Available
When is PYC Therapeutics Limited’s upcoming earnings report date?
PYC Therapeutics Limited’s upcoming earnings report date is Feb 27, 2025 which is in 96 days.
How were PYC Therapeutics Limited’s earnings last quarter?
PYC Therapeutics Limited released its earnings results on Aug 29, 2024. The company reported -AU$0.06 earnings per share for the quarter, beating the consensus estimate of -AU$0.07 by AU$0.01.
Is PYC Therapeutics Limited overvalued?
According to Wall Street analysts PYC Therapeutics Limited’s price is currently Overvalued.
Does PYC Therapeutics Limited pay dividends?
PYC Therapeutics Limited does not currently pay dividends.
What is PYC Therapeutics Limited’s EPS estimate?
PYC Therapeutics Limited’s EPS estimate is -AU$0.04.
How many shares outstanding does PYC Therapeutics Limited have?
PYC Therapeutics Limited has 447,197,660 shares outstanding.
What happened to PYC Therapeutics Limited’s price movement after its last earnings report?
PYC Therapeutics Limited reported an EPS of -AU$0.06 in its last earnings report, beating expectations of -AU$0.07. Following the earnings report the stock price went down -3.704%.
Which hedge fund is a major shareholder of PYC Therapeutics Limited?
Currently, no hedge funds are holding shares in AU:PYC
---
PYC Therapeutics Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.32 (-82.41% Downside)
AU$0.32 (-82.41% Downside)
Blogger Sentiment
Bullish
AU:PYC Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
139.34%
12-Months-Change
Fundamentals
Return on Equity
-69.70%
Trailing 12-Months
Asset Growth
145.49%
Trailing 12-Months
Company Description
PYC Therapeutics Limited
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the major challenge in RNA therapeutics - safe and effective delivery of the drug inside the cell. Geographically, it operates only in Australia.
---
PYC Stock 12 Month Forecast
Average Price Target
AU$0.32
▼(-82.41% Downside)
Technical Analysis
Arovella Therapeutics Limited
―
Race Oncology Ltd.
―
Botanix Pharmaceuticals Limited
―
Best Analysts Covering PYC
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+63.68%
reiterated a buy rating 17 days ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +63.68% per trade.
---